Exchange Traded Concepts »

Allogene Therapeutics shares owned by Exchange Traded Concepts

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Exchange Traded Concepts from 13F filings

Historical chart of Exchange Traded Concepts investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Exchange Traded Concepts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Exchange Traded Concepts

Quarter filed Position value Share count Share price at filing
2024-03-31 $283k 63k 4.47
2023-12-31 $116k 36k 3.21
2023-09-30 $85k 27k 3.17
2023-06-30 $124k 25k 4.97

More positions owned by Exchange Traded Concepts

Spdr Ser Tr Nuveen Bloomberg (HYMB)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds Real Estate Etf (VNQ)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Meta Platforms Cl A (META)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Qualcomm (QCOM)
Select Sector Spdr Tr Financial (XLF)
Select Sector Spdr Tr Technology (XLK)
Williams Companies (WMB)

View all positions for Exchange Traded Concepts

Top funds holding Allogene Therapeutics

Tpg Gp A
Vanguard Group
Jpmorgan Chase & Co
PRIMECAP Management Company
Citadel Advisors
Goldman Sachs Group
T. Rowe Price Associates
Two Sigma Investments
Millennium Management
Vida Ventures Advisors
Dimensional Fund Advisors
Two Sigma Advisers
Caxton Associates
Nordea Investment Management Ab
Charles Schwab Investment Management

View all funds holding Allogene Therapeutics